Treatment of Depression With Mindfulness, Acceptance and Commitment
赞助:
Neuropsychiatrischen Zentrums Hamburg-Altona
合作者:
信息的提供 (责任方):
Peter Tonn,Neuropsychiatrischen Zentrums Hamburg-Altona
追踪信息 | |||
---|---|---|---|
首次提交日期 ICMJE | August 23, 2018 | ||
首次发布日期e ICMJE | October 2, 2018 | ||
最后更新发布日期 | October 2, 2018 | ||
预计研究开始日期 ICMJE | November 2018 | ||
预计主要完成日期 | December 2019 (主要结果测量的最终数据收集日期) | ||
目前主要观察指标 ICMJE |
Depression - Patient Health Questionnaire-9[ Time Frame: Measurement of PHQ-Data 3 months after inclusion of participant ] Measurement of changes of depressive Symptoms, so called PHQ-9. There will be a measure of the total score, range from 9 to 36, pathological in sense of depression will be any score above 15. There is only one measurement scale (PHQ-9) with nine items, no other measurements or different units in the PHQ-9. |
||
原始主要观察测量 ICMJE | 与当前相同 | ||
目前的二级观察 ICMJE |
|
||
描述性信息 | |||
简略标题 ICMJE | Treatment of Depression With Mindfulness, Acceptance and Commitment | ||
正式标题 ICMJE | Mindfulness, Acceptance and Commitment Combined in Cognitive Behavioral Group Therapy (MAC-CBT®) for Patients With Depression | ||
简要概况 | Randomized trial to proof the effects and efficacy of a new mindfulness and acceptance based group-treatment for depressive patients |
||
详细说明 | In this study, a randomized trial is conducted in which the participants are allocated to two different care services (MAC-CBT® vs. progressive muscle relaxation). Participants are patients with depression who have been made aware of the group therapy by their treating physicians or psychotherapists or who have read the advertising in waiting areas or on the investigators homepage. An extensive psychometric survey will be conducted at the start of the study in an interview session with a psychotherapist, who also judges if the participants are able to participate in a therapy group. The MAC-CBT® group receives an eight-session group therapy, in which the aspects of mindfulness, acceptance and commitment are taught in detail. The control group will receive an eight-session treatment with progressive muscle relaxation. Input and output results are determined using validated survey instruments. In addition, the investigators will check the data for moderating variables (e.g. age, gender, previous treatments...). | ||
研究类型 ICMJE | Interventional | ||
研究阶段 | N/A | ||
研究设计 ICMJE | 分配: Randomized 干预模型: Parallel Assignment 干预模型描述: One group with new treatment, one group with known and defined treatment 盲法: Interventional 盲法描述:The participants don't know in which of the both arms they are, the outcome assessor don't know which participant of which study-arm he/she calculate 主要目的: Treatment |
||
适用条件 ICMJE | |||
干预项目 ICMJE |
|
||
研究工具 |
|
||
招募信息 | |||
招募状态 ICMJE | Not yet recruiting | ||
预计入组 ICMJE |
120 | ||
原始预计入组 ICMJE | 与当前相同 | ||
预计研究完成日期 | March 2020 | ||
预计主要完成日期 | December 2019 (主要结果测量的最终数据收集日期) | ||
合格标准 ICMJE | Inclusion Criteria: - Depressive Disorder Exclusion Criteria: - Somatic disorder - psychotic disorder - personality disorder | ||
性别 |
|
||
年龄 | 最小年龄:18 Years ,最大年龄:70 Years | ||
接受健康的志愿者 | 没有 | ||
可入组国家 ICMJE | |||
管理信息 | 数据检测委员会 | No | |
研究涉及美国FDA监管的产品 |
研究美国FDA监管的药品: No 研究涉及美国FDA监管的设备产品: No |
||
IPD 共享声明 |
|
||
责任方 | Peter Tonn,Neuropsychiatrischen Zentrums Hamburg-Altona | ||
研究赞助商 ICMJE | Neuropsychiatrischen Zentrums Hamburg-Altona | ||
合作者 ICMJE | |||
研究员 ICMJE |
|
||
PRS 账户 | Neuropsychiatrischen Zentrums Hamburg-Altona | ||
验证日期 | October 2018 | ||
ICMJE 国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素 |
请使用微信扫码报名